CCTG

ALC.6 | A041501

NCT03150693

ALC.6

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Status:

Recruiting

26459-200.png

III

Phase

Line of Therapy.png

1st

Line of Therapy

Disease Stage.png

Early Cancer

Disease Stage

Target.png

Biomarker(s)

N/A

Investigational

Product

Inotuzumab Ozogamicin

Antibody‒Drug Conjugate (i.v.)

Treatment Arms

o Experimental: Arm II (frontline chemotherapy, inotuzumab ozogamicin)

o Active Comparator: Arm I (frontline chemotherapy)